A. Arora and E. M. Scholar, Role of tyrosine kinase inhibitors in cancer therapy, J. Pharmacol. Exp. Ther, vol.315, pp.971-979, 2005.

L. M. Rogers, S. Veeramani, and G. J. Weiner, Complement in monoclonal antibody therapy of cancer, Immunol. Res, vol.59, pp.203-210, 2014.

A. M. Chakrabarty, N. Bernardes, and A. M. Fialho, Bacterial proteins and peptides in cancer therapy: Today and tomorrow, vol.5, pp.234-242, 2014.

B. Lepenies, J. Lee, and S. Sonkaria, Targeting C-type lectin receptors with multivalent carbohydrate ligands, Adv. Drug Deliv. Rev, vol.65, pp.1271-1281, 2013.

P. Bojarova and V. Kren, Sugared biomaterial binding lectins: Achievements and perspectives, Biomater. Sci, vol.4, pp.1142-1160, 2016.

M. Swierczewska, H. S. Han, K. Kim, J. H. Park, and S. Lee, Polysaccharide-based nanoparticles for theranostic nanomedicine, Adv. Drug Deliv. Rev, 2016.

A. K. Adak, B. Y. Li, and C. C. Lin, Advances in multifunctional glycosylated nanomaterials: Preparation and applications in glycoscience, Carbohydr. Res, vol.405, pp.2-12, 2015.

G. Yilmaz and C. R. Becer, Glyconanoparticles and their interactions with lectins, Polym. Chem, vol.6, pp.5503-5514, 2015.

K. G. Liu, X. H. Jiang, and P. Hunziker, Carbohydrate-based amphiphilic nano delivery systems for cancer therapy, Nanoscale, vol.8, pp.16091-16156, 2016.

M. Marradi, F. Chiodo, I. Garcia, and S. Penades, Glyconanoparticles as multifunctional and multimodal carbohydrate systems, Chem. Soc. Rev, vol.42, pp.4728-4745, 2013.

M. J. Vicent and R. Duncan, Polymer conjugates: Nanosized medicines for treating cancer, Trends Biotechnol, vol.24, pp.39-47, 2006.

X. Wang, O. Ramstrom, and M. Yan, Glyconanomaterials: Synthesis, characterization, and ligand presentation, Adv. Mater, vol.22, pp.1946-1953, 2010.

N. C. Reichardt, M. Martin-lomas, S. Penades, and . Glyconanotechnology, Chem. Soc. Rev, vol.42, pp.4358-4376, 2013.

O. Vaillant, K. El-cheikh, D. Warther, D. Brevet, M. Maynadier et al., Mannose-6-phosphate receptor: A target for theranostics of prostate cancer, Angew. Chem. Int. Ed. Engl, vol.54, pp.5952-5956, 2015.

S. Kornfeld, Structure and function of the mannose 6-phosphate/insulin-like growth factor II receptors, Annu. Rev. Biochem, vol.61, pp.307-330, 1992.

S. Vidal, M. Garcia, J. L. Montero, and A. Morere, Synthesis and biological evaluation of new mannose 6-phosphate analogues, Bioorg. Med. Chem, vol.10, pp.4051-4056, 2002.

A. Jeanjean, M. Garcia, A. Leydet, J. L. Montero, and A. Morere, Synthesis and receptor binding affinity of carboxylate analogues of the mannose 6-phosphate recognition marker, Bioorg. Med. Chem, vol.14, pp.3575-3582, 2006.
URL : https://hal.archives-ouvertes.fr/inserm-00144764

D. B. Berkowitz, G. Maiti, B. D. Charette, C. D. Dreis, and R. G. Macdonald, Mono-and bivalent ligands bearing mannose 6-phosphate (M6P) surrogates: Targeting the M6P/insulin-like growth factor II receptor, Org. Lett, vol.6, pp.4921-4924, 2004.

S. Vidal, C. Vidil, A. Morere, M. Garcia, and J. L. Montero, Synthesis and biological evaluation of two mannose 6-phosphate analogs, Eur. J. Org. Chem, pp.3433-3437, 2000.

A. Jeanjean, M. Gary-bobo, P. Nirde, S. Leiris, M. Garcia et al., Synthesis of new sulfonate and phosphonate derivatives for cation-independent mannose 6-phosphate receptor targeting, Bioorg. Med. Chem. Lett, vol.18, pp.6240-6243, 2008.
URL : https://hal.archives-ouvertes.fr/inserm-00339550

A. Varki and S. Kornfeld, Structural studies of phosphorylated high mannose-type oligosaccharides, J. Biol. Chem, vol.255, pp.10847-10858, 1980.

J. J. Distler, J. F. Guo, G. W. Jourdian, O. P. Srivastava, and O. Hindsgaul, The binding specificity of high and low molecular weight phosphomannosyl receptors from bovine testes. Inhibition studies with chemically synthesized 6-O-phosphorylated oligomannosides, J. Biol. Chem, vol.266, pp.21687-21692, 1991.

D. Brevet, M. Gary-bobo, L. Raehm, S. Richeter, O. Hocine et al., Mannose-targeted mesoporous silica nanoparticles for photodynamic therapy, Chem. Commun, pp.1475-1477, 2009.
URL : https://hal.archives-ouvertes.fr/hal-00367691

O. Hocine, M. Gary-bobo, D. Brevet, M. Maynadier, S. Fontanel et al., Silicalites and mesoporous silica nanoparticles for photodynamic therapy, Int. J. Pharm, vol.402, pp.221-230, 2010.
URL : https://hal.archives-ouvertes.fr/hal-00575771

M. Gary-bobo, O. Vaillant, M. Maynadier, I. Basile, A. Gallud et al., Targeting multiplicity: The key factor for anti-cancer nanoparticles, Curr. Med. Chem, vol.20, 1946.
URL : https://hal.archives-ouvertes.fr/hal-00841552